𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation

✍ Scribed by James Neuberger; Bridget Gunson; Stefan Hubscher; Peter Nightingale

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
75 KB
Volume
10
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Primary biliary cirrhosis after liver tr
Primary biliary cirrhosis after liver transplantation: Influence of immunosuppression and human leukocyte antigen locus disparity
✍ Pinelopi Manousou; Vasiliki Arvaniti; Emmanuel Tsochatzis; Graziella Isgro; Kate πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 211 KB

Patients with primary biliary cirrhosis (PBC), despite excellent outcomes after liver transplantation (LT), may develop recurrent primary biliary cirrhosis (rPBC). The impact of immunosuppression and HLA mismatches on rPBC is unclear. We evaluated 103 consecutive PBC patients who underwent transplan

Recurrence of autoimmune disease, primar
Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation
✍ Jean-Charles Duclos-Vallee; MylΓ¨ne Sebagh πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 424 KB πŸ‘ 1 views

1. Recurrence of primary sclerosing cholangitis. a Five percent of liver transplants are performed because of end-stage liver disease secondary to primary sclerosing cholangitis. b Recurrent disease affects 10% to 27% of recipients. c Diagnostic criteria of recurrence include the following: A confir

Cirrhosis after orthotopic liver transpl
Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence
✍ Moataz Seyam; James M. Neuberger; Bridget K. Gunson; Stefan G. HΓΌbscher πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 1 views

Liver allograft cirrhosis is a relatively uncommon complication of liver transplantation. Most cases can be attributed to disease recurrence, particularly recurrent hepatitis C. Little is known about the frequency, etiology, and natural history of liver allograft cirrhosis occurring without evidence

Long-term survival and impact of ursodeo
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation
✍ Phunchai Charatcharoenwitthaya; Sylvania Pimentel; Jayant A. Talwalkar; Felicity πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 275 KB πŸ‘ 1 views

The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long-term follow-up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known. The aims of this study were